Compare Adaptive Biotechnologies Corp (ADPT) vs Petróleo Brasileiro SA (PBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Petróleo Brasileiro SA — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Petróleo Brasileiro SA trades at $17.94 (market cap $112.19B). The key difference: Petróleo Brasileiro SA is far larger — about 27.8× Adaptive Biotechnologies Corp's market cap, and Petróleo Brasileiro SA pays a 9.42% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | PBR | |
|---|---|---|
Market Cap | $4.04B | $112.19B |
Sector | Health | Technology |
52-Week High | $25.45 | $22.03 |
52-Week Low | $12.30 | $11.54 |
Enterprise Value | $4.10B | $172.61B |
Dividend Yield | — | 9.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Petróleo Brasileiro SA
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →
